Thursday 13 August 2020
Home      All news      Contact us      Chinese
todayonline - 1 month ago

Emergent to make drug substance for J J s COVID-19 vaccine candidate

Emergent BioSolutions Inc lt;EBS.N gt; said on Monday it has signed a five-year pact to make the drug substance used in Johnson Johnson s lt;JNJ.N gt; COVID-19 vaccine candidate, in a deal valued at about $480 million for the first two years. Johnson Johnson had struck a deal with Emergent in April to use its manufacturing facilities and make more than 1 billion doses of a vaccine it is testing to stop the novel coronavirus. REUTERS


Latest News
Hashtags:   

Emergent

 | 

substance

 | 

COVID

 | 

vaccine

 | 

candidate

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)

Sources